Back to Search
Start Over
[Anti-MOG associated disease].
- Source :
-
Revue medicale suisse [Rev Med Suisse] 2024 Apr 24; Vol. 20 (871), pp. 828-832. - Publication Year :
- 2024
-
Abstract
- Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD) is an autoimmune disease responsible for demyelination of the central nervous system that can occur in adults or children. Overlapping phenotypes between MOGAD, multiple sclerosis (MS) and neuromyelitis optica spectrum disease (NMOSD) have been described. The diagnostic criteria for MOGAD were proposed by a panel of international experts and published in 2023. Defining clinical, biological and imaging characteristics specific to this entity helps to improve diagnostic specificity. In this article, we present the clinical characteristics suggestive of MOGAD and discuss the importance of the antibody detection method and therapeutic management.<br />Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
- Subjects :
- Humans
Adult
Child
Autoimmune Diseases diagnosis
Autoimmune Diseases immunology
Myelin-Oligodendrocyte Glycoprotein immunology
Neuromyelitis Optica diagnosis
Neuromyelitis Optica immunology
Autoantibodies immunology
Autoantibodies blood
Multiple Sclerosis diagnosis
Multiple Sclerosis immunology
Subjects
Details
- Language :
- French
- ISSN :
- 1660-9379
- Volume :
- 20
- Issue :
- 871
- Database :
- MEDLINE
- Journal :
- Revue medicale suisse
- Publication Type :
- Academic Journal
- Accession number :
- 38665102
- Full Text :
- https://doi.org/10.53738/REVMED.2024.20.871.828